ReWalk Robotics Ltd (NASDAQ:RWLK)’s share price traded down 14.8% during trading on Friday . The stock traded as low as $1.10 and last traded at $1.15. 4,143,280 shares changed hands during mid-day trading, an increase of 1,027% from the average session volume of 367,667 shares. The stock had previously closed at $1.35.
Several equities analysts recently commented on the stock. Jefferies Group LLC decreased their price objective on shares of ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, November 3rd. Oppenheimer Holdings, Inc. set a $4.00 price objective on shares of ReWalk Robotics and gave the company a “buy” rating in a research report on Friday, August 4th. Canaccord Genuity reissued a “buy” rating and set a $3.00 price target on shares of ReWalk Robotics in a research report on Monday, November 6th. Finally, Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research report on Thursday, November 9th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $3.00.
The company has a debt-to-equity ratio of 7.46, a quick ratio of 1.65 and a current ratio of 2.02.
A number of institutional investors have recently added to or reduced their stakes in RWLK. Advisor Group Inc. grew its stake in ReWalk Robotics by 1,495.6% in the 3rd quarter. Advisor Group Inc. now owns 181,900 shares of the medical device company’s stock valued at $264,000 after acquiring an additional 170,500 shares during the period. Essex Investment Management Co. LLC grew its stake in ReWalk Robotics by 328.7% in the 3rd quarter. Essex Investment Management Co. LLC now owns 156,981 shares of the medical device company’s stock valued at $228,000 after acquiring an additional 120,362 shares during the period. Finally, Renaissance Technologies LLC grew its stake in ReWalk Robotics by 61.7% in the 1st quarter. Renaissance Technologies LLC now owns 78,600 shares of the medical device company’s stock valued at $165,000 after acquiring an additional 30,000 shares during the period. 4.62% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://sportsperspectives.com/2017/11/19/rewalk-robotics-ltd-rwlk-stock-price-down-14-8.html.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.